Skip to main content
JA Clinical Reports
Fig. 1 | JA Clinical Reports

Fig. 1

From: Successful use of an antithrombin for heparin resistance with andexanet alfa

Fig. 1

Infusion of andexanet alfa, heparin, antithrombin and coagulation parameters during anesthesia. Activated coagulation time (ACT) was 253 s following infusion of unfractionated heparin 30000 U, which was still 240 s after additional heparin 30000 U. ACT was 514 s after administration of antithrombin 3000 IU, with prolonged coagulation time measured by thromboelastography. CPB, cardiopulmonary bypass; ACT, activated clotting time; AT, antithrombin; UFH, unfractionated heparin. × : Start of anesthesia. ◎: Start of operation

Back to article page